alexa Nosocomial <em>Clostridium difficile</em> Infection among Patients Over 90 Years Old | OMICS International
ISSN: 2332-0877
Journal of Infectious Diseases & Therapy
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Nosocomial Clostridium difficile Infection among Patients Over 90 Years Old

Yuji Hirai1,2*, Midori Miyamae2, Toru Yamada2 and Shin Takahashi2

1Department of General Medicine, Faculty of Medicine, Juntendo University, Japan

2Tokyo Metropolitan Health and Medical Treatment Corporation, Tama-Hokubu Medical Center, Infection Control Team, Japan

*Corresponding Author:
Yuji Hirai
Department of General Medicine, Faculty of Medicine
Juntendo University, Hongo, Bunkyo, Tokyo, Japan
Tel: +81-3-3813-3111
Fax: +81-3-5684-7830
E-mail: [email protected]

Received date: August 25, 2017; Accepted date: September 05, 2017; Published date: September 09, 2017

Citation: Hirai Y, Miyamae M, Yamada T, Takahashi S (2017) Nosocomial Clostridium difficile Infection among Patients Over 90 Years Old. J Infect Dis Ther 5:333. doi: 10.4172/2332-0877.1000333

Copyright: © 2017 Hirai Y, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Infectious Diseases & Therapy

Abstract

Aim: Ageing population trends indicate that the median life expectancy in Japan is increasing. Clostridium difficile infection (CDI) can be a fatal nosocomial infection among the geriatric population. We examined clinical outcome and risk factors associated with death due to CDI among patients >90 years old.

Methods: This retrospective observational study was performed to demonstrate the clinical characteristics of Patients >90 years who developed CDI between April 2010 and March 2015 at Tama-Hokubu Medical Center (a 344-bed community tertiary care hospital; average age of inpatients: 72 years). Diagnosis of CDI was confirmed via an enzyme-linked immunosorbent assay using stool sample. Multivariate analysis was performed to determine the independent risk factors associated with death.

Results: Twenty-nine patients with CDI confirmed were identified. The mean age was 93 (90–100) years and 37.9% were women. Patients presented with hypertension (37.9%) and diabetes (33%) as underlying diseases, and 93.1% were admitted from long-term care facilities. The median period from admission to onset of CDI was 14 (2– 73) days. The average episodes of diarrhea was 3.96 (1 to 10) times per day. The overall 90-day mortality rate was 34.5%. Multivariate analysis revealed that arrhythmia followed by onset of CDI (Odds Ratio, 8.0; 95% Confidence Interval, 1.37–46.8; P=0.021) was an independent risk factor associated with death.

Conclusions: Arrhythmia followed by onset of CDI is a risk factor for death. Strict clinical management, including continuous monitoring of electrolyte and fluid balance and careful observation of patients >90 years old is crucial.

Keywords

Clostridium difficile infection; Geriatric population; Developing arrhythmia

Introduction

Clostridium difficile infection (CDI) is a fatal nosocomial infection among the geriatric population. In the United States, the mortality rate was reported to steadily increase, from 5.7 per million in 1999 to 23.7 per million in 2004. The median age of these deceased patients was 82 years [1]. In the United Kingdom, 81% of all patients with CDI were >65 years of age and 30% were >80 years [2]. Aging population trends indicate that the median life expectancy in Japan is increasing (80 years old in male and 82 years old in female). Patients >90 years of age admitted to tertiary care hospitals generally require intensive medical care. To date, CDI patients over 65 years of age have been described en bloc as a “geriatric population” [2-4]. The clinical characteristics of CDI within this group show further variation according to age subgroups [2]. We aimed to demonstrate the clinical characteristics including risk factor associated with death of CDI among patients over >90 years of age in a tertiary care hospital.

Methods

This retrospective study reviewed the medical records of patients at Tama-Hokubu Medical Centre (a 344-bed community tertiary care hospital) between April 2010 and March 2015. Nosocomial CDI was defined as a positive enzyme-linked immunosorbent assay (ELISA; TOX A/B QUICK (from April 2000 to November 2011), C.DIFF QUICK CHECK COMPLETE, (from November 2011 to March 2015), Alere, Florida, USA) result using stool samples obtained >48 h after admission. Patients >90 years of age who developed nosocomial CDI were included in the study. Data recorded included age, sex, underlying diseases, cause of admission, initial antimicrobial agents used, Proton Pump Inhibitors (PPI) used, median time from admission to onset of CDI (days), daily episodes of diarrhea (times per day) at the onset of CDI, treatment of CDI, development of arrhythmia followed by CDI, vital signs at diagnosis of CDI, and overall mortality within 90 days of admission. Laboratory data, including white blood cell count (WBC) and serum C-reactive protein (CRP), brain natriuretic peptide (BNP), albumin, and electrolyte were also recorded. Continuous data were compared using the t test and categorical data were compared using Fisher‘s exact tests. Multivariate analysis was performed to determine the independent risk factors associated with death using forward stepwise logistic regression. All variables with P<0.1 in the univariate analysis were included in the multivariate model, with the level of significance set at P<0.05 Statistical analyses were performed using R version 3.3.1 for Microsoft Windows 10. The study protocol was approved by the Ethics Committee at Tama-Hokubu Medical Centre.

Results

Twenty-nine patients with CDI were included in the study (Table 1). The mean age was 93 (90–100) years, and 11 (37.9%) patients were women. Patients presented with the following underlying conditions: hypertension (37.9%); diabetes (33%); chronic heart failure (27.5%), renal impairment (24.1%); orthopedic diseases, such as femoral neck fracture (20.7%); dementia (13.8%); ischemic heart diseases (13.8%), and malignancy (12.2%). No one had cardiovascular surgery, coronary intervention therapy, and Cardiac Implanted Electric Devices (CIED) was found among study population. Out of 29 patients, 27 (93.1%) were transferred from long-term care facilities (LTCF) or nursing homes (NH) and 6.9% were admitted from home. All of case had been admitted LTCF. The cause of admission in 58.6% of patients was community-acquired or aspiration pneumonia. Initial treatment consisted of penicillin mono therapy or in combination with beta-lactamase inhibitors (58.6%) (ampicillin-sulbactam, piperacillin-tazobactam) and carbapenems (20.7%). Thus, 65.5% of patients were administered antimicrobials to which anaerobic organisms are generally susceptible. No one took oral or intravenous fluoroquinolone during or before admission as far as description of medical records. And 48.3% of patients took PPI. The initial clinical presentation was watery diarrhea (100% of cases). The median period from admission to onset of CDI was 14 (2–73) days. The average number of episodes of diarrhea was 3.96 (1 to 10) per day at the day of onset CDI. Vital signs at diagnosis of CDI were as follows: median body temperature, 36.3 (35.8-38.1) °C, with 58.6% of patients having a body temperature <37 °C; median heart rate was 79 (52-108) beats per minute. A new episode of arrhythmia (paroxysmal atrial fibrillation (n=5), non-sustained ventricular tachycardia (n=1), incomplete right bundle branch block (n=1), complete atrial ventricle block (n=1), or ventricular premature complexes (n=1)) was followed by CDI in 31.3% of patients. The median days from onset CDI to developing arrhythmia was 4 (1-11) days. All cases demonstrated positive ELISA results (TOX A/B QUICK until November, 2011, C.DIFF QUICK CHECK COMPLETE, Alere, Florida, USA). Laboratory test results were as follows: median WBC count, 8700 (3500–24500) cells/μL; median CRP level, 2.91 (0.2–21.2) mg/dL; median BNP level (n=9), 899.7 (66.7–2777.3) pg/mL; and blood urine nitrogen level, 20.1 (3.2–98.2) mg/dL. Oral metronidazole was administered in 82.3% of patients while oral vancomycin was administered in 6.9% of patients. Overall mortality rate was 34.5% over 90 days. The median time from onset to death was 20.5 (4–55) days and 60% of deaths were associated with serum electrolyte imbalances, such as hyponatremia and hypopotassemia. In the univariate analysis, no significant difference in the clinical characteristics of the participants was observed between survivors and deceased patients. Multivariate analysis indicated that arrhythmia followed by onset of CDI (Odds Ratio (OR), 8.0; 95% Confidence Interval (CI), 1.37–46.8; P=.021) was an independent risk factor for death (Table 1). No recurrent cases of CDI were found among the study population.

  Overall (n=29) Survived (n=19) Died (n=10) Univariate Analyses Multivariate Analyses OR (95%CI; p value)
Median Age (years old) 93 (90 - 100)        
Gender (male) 11 (37.9%) 7 3 1  
Underlying Diseases          
Hypertension 11 (37.9%) 7 4 1  
Renal Impairment 7 (24.1%) 3 4 0.193  
Dementia 4 (13.8%) 3 1 1  
Malignancy 6 (20.7%) 3 3 0.633  
Diabetes 1 (3.3%) 0 1 0.345  
Proton Pump Inhibitor Use 14 (48.3%) 9 5 1  
Heart Failure 8 (27.5%) 4 4 0.445  
Ischemic Heart Disease 4 (13.8%) 2 2 0.592  
Cause of Admission          
Pneumonia 17 (58.6%) 10 7 0.449  
Orthopedic Diseases 6 (20.7%) 4 2 1  
Colorectal Diseases 4 (13.8%) 4 0 0.268  
Others 6 (20.7%) 6 0 0.0676  
Initial Antimicrobial Used          
PC +/- BLI 17 (58.6%)        
Carbapenems 6 (20.7%)        
Susceptible to Anaerobe 19 (65.5%) 12 7 1  
CDI          
From Admission To Onset Of CDI (days) 14 (2-73) 14 (2-73) 19 (8-54) 0.679  
Diarrhea (times per day) at diagnosis 3.96 (1- 10) 4 (1-10) 2 (1-5) 0.0555  
Oral MNZ Treatment 24 (82.3%) 15 9 0.633  
Oral VCM Treatment 2 (6.9%) 0 2 0.111  
At Diagnosis Of CDI          
Median Body Temperature () 36.3 (35.8-38.1)        
Body Temperature<37 17 (58.6%) 9 8 0.126  
Median BP (mmHg) 120 (91-172) 120 (96-168) 116.5 (91-172) 0.765  
Heart Rate (/min.) 79 (52-105) 80 (52-105) 74 (60-108) 0.945  
Heart Rate>80 (/min.) 14 (48.3%) 10 4 0.7  
WBC ( × 103/μL)* 8.7 (3.5-24.5) 8.6 (4.6-25.0) 9.4 (3.5-16.9) 1  
WBC>8000 (/μL) 20 (69%) 14 6 1  
Serum Albumin* 2.8 (1.7-4.4) 2.9 (2.1-4.4) 2.7 (1.7-3.3) 0.25  
CRP (mg/dL)* 2.91 (0.2-21.2) 2.91 (0.4-21.25) 3.22 (0.02-13) 0.636  
CRP>10 (mg/dL) 5 (17.2%) 3 2 1  
BNP (pg/mL)* 899.7 (66.7-3136) 450 (66.7-3136) 1867.5 (771-2793) 0.286  
BNP>500 (pg/mL) 5 (17.2%) 1 4 0.0476 OR 9.26 (0.72-119; p=0.087)
Serum BUN (mg/dL) 20.1 (3.2-98.2) 14.9 (3.2-59.2) 38.05 (7.7-98) 0.119  
BUN>20 (mg/dL) 15 (51.7%) 8 7 0.245  
Hyponatremia (Na<135 mEq/L) 10 (34.5%) 7 3 1  
Hypopotassemia ( K<3.5 mEq/L ) 7 (24.1%) 3 4 0.193 OR 5.32 (0.59-47.6; p=0.135)
A New Arrhythmia Followed By CDI 9 (31%) 3 6 0.0317 OR 8.0 (1.37-46.8; p=0.021)
Days From Onset CDI to Arrhythmia* 4 (1-11) 3.5 (1-11) 4 (2-9) 1  
Overall Mortality In 90 days 10 (34.5%)        
Days From Onset CDI To Death* 20.5 (4-55)        
CDI: Clostridium difficile Infection; BNP: Brain Natriuretic Peptide; BLI: Beta-Lactamase Inhibitor; PC: Penicillin; BP: Blood Pressure; MNZ: Metronidazole; VCM: Vancomycin; WBC: White Blood Cell Count; CRP: C-reactive Protein; BUN: Blood Urine Nitrogen; CI: Confidence Interval; OR: Odds Ratio; *: median.

Table 1: Characteristics of patients over 90 years of age with CDI, Univariate/ Multivariate analyses.

Discussion

CDI can be fatal among elderly patients. The median life expectancy is reaching 90 years (80 years in male and 82 years in female) in Japan. The incidence of exposure to antibiotics among elderly people is increasing, due to community-acquired or nosocomial infections, such as pneumonia. The extreme geriatric population (patients >90 years old) [3] may have a higher incidence of developing CDI compared to the younger geriatric population [2]. Out of the total study population, 93% of patients were transferred to our hospital from a LTCF or NH. The incidence of CDI in NHs ranged 0.52–0.67 per 10,000 resident care days [5]. Although the carriage rate of C. difficile among residents at LTCF or NHs remains unclear, health care workers and patients residing in LTCF or NHs may be reservoirs for C. difficile [6,7]. Antibiotic stewardship programs (ASP) have shown a significant protective effect (pooled risk ratio 0.48; 95% CI 0.38-0.62) on CDI in recent meta-analyses [8,9]. Therefore, strengthening ASP and promoting strict infection control can reduce the incidence of CDI in the elderly population in NHs and LTCF. In addition, the economic burden of CDI in developed countries, including the United States and Canada [10,11] have been reported. Of note, the median cost of pharmacological treatment for patient with recurrent CDI while hospitalization was much higher than that of primary CDI (US$140 vs. US$60, P=0.0013) [12].

Ticinesi et al. [13] studied 505 elderly (≥ 65 years old) hospitalized patients and found that the incidence of developing CDI was 8.5% (43/505) and that a Cumulative Illness Rating Scale (CIRS) score ≥ 17 (OR 5.07, 95% CI; 1.28-20.14, P=0.02) and antibacterial therapy (OR 2.61, 95% CI; 1.21-5.64, P=0.01) are independent risk factors associated with developing CDI in the multivariate logistic regression model. The CIRS score is focused on geriatric population and is a risk factor for CDI comorbidity and mortality. Where CDI is suspected among geriatric patients, CIRS may be a useful tool for clinical diagnosis and appropriate infection control management. The majority of hospitalized patients with CDI were treated with antibiotics for infectious diseases, such as pneumonia. Predict to a complicated clinical course in CDI was discussed. 12% among 395 CDI hospitalized patients had a complicated course. Age over 85 years (OR 4.96, 95% CI; 1.4-17.6, P= 0.01) is a significant and strong independent predictor of CDI in multivariable analyses [14]. Thus extreme age, such as over 90 years old, is an important risk factor for CDI [15] and for developing complications or recurrence of CDI [12].

A study involving 72 patients (mean age 81 years old) at 4 NHs found that 69% of patients developed CDI within 30 days (10.5 ± 2.5 days) of admission to hospital, corroborating our results [5]. Generally, increased WBC and fever (>38) have been reported in patients with CDI. However, our results showed that only 41.4% of 90 year old patients developed a body temperature >37 and 31% had elevated WBC (>8000/μL). Therefore, except for diarrhea, clinical symptoms among elderly patients with CDI are atypical, compared to general population. Furthermore, difficulty in defecation, such as chronic constipation and diarrhea, are common in geriatric patients. The incidence of CDI among elderly patients may be underestimated because of this atypical presentation [16] and, as a result, in general practice, only 40% of all cases of CDI were detected. Multivariable analysis revealed that use of antibiotics (OR, 6.88; 95% CI, 3.97-11.9; P<0.01) and cancer (OR, 4.04; 95% CI, 1.47–11.1; P<0.01), which were recognized as general risk factor, were strongly associated with CDI. Age ≥ 50 years old was not a significant risk factor (OR, 1.41; 95% CI, 0.79–2.52; P<0.25) [17].

Our results showed a mortality rate of 34.5% among patients >90 years old with CDI. This is comparable to the reported mortality rate among patients with CDI >65 years [18]. Generally, age >65 years in patients with CDI was considered a risk factor associated with death [19]. However, to date, risk factors other than age, hyper-virulent Clostridium difficile strain, antibiotic use, or PPI use [20] remain unclear. Approximately a half of study population took PPI. The use of PPI may affect to develop or recurrence of CDI20. Similar to ASP, appropriate use of PPI, if I was to say ‘PPI stewardship’, should be considered to prevent CDI.

This is the first report to show that arrhythmia followed by onset of CDI is an independent risk factor associated with death. A previous study involving patients >80 years of age, reported an association between coronary artery disease (OR 5.5, 95% CI; 1.2-23, P=0.02) and death in 90-days among patients [21]. This may corroborate our results. Dehydration, with serum electrolyte imbalance, caused by CDI, can strongly affect the development of a new episode of arrhythmia. Therefore, intensive general care, including strict management of fluid and electrolyte balance, is required for Clostridium difficile -infected patients aged >90 years.

This study has four limitations. First, it was an observational retrospective study with only 29 patients. Further multi-institutional studies are required. Second, according to guidelines, the indication for ELISA test for stool samples is generally recognized that patients develop diarrhea (≥ 3 times per day) with Bristol score more ≥ 5. However, geriatric patients with CDI develop atypical clinical symptoms. Thus, patients with diarrhea ≥ 1 time per day at ELISA test were also included our study. Third, hyper-virulent Clostridium difficile strains (i.e. B1/NAP1/027), have recently spread across North America; however, these are extremely rare in Japan. To detect these strains was not performed in this study. Finally, some of arrhythmias followed by onset of CDI may be a simple result of altered electrolyte and fluid balance in combined with underlying heart diseases of patients.

In conclusion, this study has shown that strict and continuous clinical management, including management of electrolyte and fluid balance, and careful observation of patients >90 years with CDI is crucial. With the current ageing population trend, further investigations to establish infection control measures for LTCF, NHs, and home environments, are required.

Acknowledgements

The results of this study were presented as a poster (Abstract number P1103) at the European Conference of Clinical Microbiology and Infectious Diseases (ECCMID) 2016, Amsterdam, Netherlands, April 9-12, 2016. The authors thank for Mrs. Shinobu Tase, and Dr. Hideki Akiyama.

Disclosure Statement

Dr. Yuji Hirai received research funding from Daiichi Sankyo Company Limited, as relevant financial activities outside the submitted work.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 498
  • [From(publication date):
    October-2017 - May 23, 2018]
  • Breakdown by view type
  • HTML page views : 449
  • PDF downloads : 49
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7